211
Participants
Start Date
April 11, 2017
Primary Completion Date
June 15, 2022
Study Completion Date
June 15, 2022
AGEN2034
Anti-programmed cell death protein-1 (PD-1) Monoclonal Antibody
East-Tallinn Central Hospital, Tallinn
Cliniques Universitaires Saint-Luc, Brussels
Pindara Private Hospital, Benowa
Calvary North Adelaide Hospital, North Adelaide
Centre Antoine-Lacassagne, Nice
Vall d'Hebron Institut d'Oncologia, Barcelona
Hospital Clínic de Barcelona, Barcelona
L'Institut Paoli - Calmettes, Marseille
CHU Hôpital de la Timone, Marseille
North Estonia Medical Centre Foundation, Tallinn
Clinique Armoricaine de Radiologie, Plérin
Clínica Universidad de Navarra, Madrid
Augusta Oncology, Augusta
Institut Claudius Regaud, Toulouse
Institut Bergonié, Bordeaux
Sylvester Comprehensive Cancer Center, Miami
Florida Cancer Specialists & Research Institute, Sarasota
The Ohio State University Comprehensive Cancer Center, Columbus
Institute de Cancerologie de l'Ouest (ICO) - René Gauducheau, Saint-Herblain
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Centre Léon Bérard, Lyon
The University of Oklahoma Health Sciences Center, Oklahoma City
Hôpital Cochin, Paris
Groupe Hospitalier Diaconesses Croix Saint-Simon - Hopital de la Croix Saint-Simon, Paris
The University of Texas MD Anderson Cancer Center, Houston
HonorHealth Research Institute, Scottsdale
University of Southern California - Keck School of Medicine, Los Angeles
City of Hope, Duarte
Gustave Roussy, Villejuif
Swedish Medical Center-Cherry Hill Campus, Seattle
Centro Oncológico del Norte, Antofagasta
Centro De Investigación Del Cancer James Lind, Temuco
Fundación Arturo López Pérez, Santiago
Bradford Hill, Santiago
Dana Farber Cancer Institute, Boston
IMIP, Recife
Instituto Nacional de Câncer, Rio de Janeiro
Hospital de Caridade de Ijuí, Ijuí
Hospital Mãe de Deus, Porto Alegre
Instituto do Cancer do Estado de São Paulo, São Paulo
Hospital Amaral Carvalho, São Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto
Szpital Swietego Rafala w Krakowie, Krakow
Szpitale Pomorskie Sp. z o.o., Gdynia
Lead Sponsor
Agenus Inc.
INDUSTRY